STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity

被引：8
|
作者：
Glickman, Laura Hix
Kanne, David B.
Kasibhatla, Shailaja
Li, Jie
Pferdekamper, AnneMarie Culazzo
Gauthier, Kelsey Sivick
Deng, Weiwen
Desbien, Anthony L.
Katibah, George E.
Leong, Justin J.
Sung, Leonard
Metchette, Ken
Ndubaku, Chudi
Zheng, Lianxing
Cho, Charles
Feng, Yan
McKenna, Jeffrey M.
Tallarico, John A.
Bender, Steven L.
Dubensky, Thomas W.
McWhirter, Sarah M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1445
引用
收藏
页数：3
相关论文
共 50 条
  • [1] STING activation in the tumor microenvironment using a synthetic human STING-activating cyclic dinucleotide induces potent antitumor immunity
    McWhirter, Sarah M.
    Glickman, Laura Hix
    Desbien, Tony
    Gauthier, Kelsey Sivick
    Kanne, David
    Kasibhatla, Shailaja
    Li, Jie
    Pferdekamper, AnneMarie Culazzo
    Katibah, George
    Lemmens, Ed
    Corrales, Leticia
    Leong, Meredith
    Ndubaku, Chudi
    Leong, Justin
    Sung, Leonard
    Zheng, Lianxing
    Cho, Charles
    Feng, Yan
    McKenna, Jeffery M.
    Tallarico, John A.
    Bender, Steven L.
    Dubensky, Thomas W., Jr.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [2] Activation of tumor-initiated T cell priming and tumor destruction with potent STING-activating cyclic dinucleotide derivatives
    Glickman, Laura Hix
    Kanne, David B.
    McWhirter, Sarah M.
    Leong, Meredith L.
    Lemmens, Edward E.
    Metchette, Ken
    Vance, Russell E.
    Pardoll, Drew M.
    Dubensky, Thomas W.
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
    Corrales, Leticia
    Glickman, Laura Hix
    McWhirter, Sarah M.
    Kanne, David B.
    Sivick, Kelsey E.
    Katibah, George E.
    Woo, Seng-Ryong
    Lemmens, Edward
    Banda, Tamara
    Leong, Justin J.
    Metchette, Ken
    Dubensky, Thomas W., Jr.
    Gajewski, Thomas F.
    CELL REPORTS, 2015, 11 (07): : 1018 - 1030
  • [4] Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity
    Glickman, Laura Hix
    Corrales, Leticia
    Kanne, David B.
    Kasibhatla, Shailaja
    Li, Jie
    Pferdekamper, Anne Marie Culazzo
    Gauthier, Kelsey Sivick
    Katibah, George E.
    Leong, Justin J.
    Sung, Leonard
    Metchette, Ken
    Deng, Weiwen
    Desbien, Anthony L.
    Ndubaku, Chudi
    Zheng, Lianxing
    Cho, Charles
    Feng, Yan
    McKenna, Jeffery M.
    Tallarico, John A.
    Bender, Steven L.
    McWhirter, Sarah M.
    Gajewski, Thomas F.
    Dubensky, Thomas W.
    CANCER RESEARCH, 2016, 76
  • [5] Potent in situ cancer immunotherapy with synthetic human STING-activating cyclic dinucleotides
    Glickman, Laura Hix
    Kanne, David B.
    Gauthier, Kelsey E.
    Katibah, George E.
    Leong, Justin J.
    Metchette, Ken
    Dubensky, Thomas W.
    McWhirter, Sarah M.
    CANCER RESEARCH, 2015, 75
  • [6] STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity
    Tabar, Mohammad Mahdi Mokhtari
    Fathi, Mahnaz
    Kazemi, Fatemeh
    Bazregari, Ghazal
    Ghasemian, Abdolmajid
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [7] Effective immunotherapy regimens incorporating highly active human STING-activating cyclic dinucleotide derivatives
    Glickman, Laura Hix
    Corrales, Leticia
    McWhirter, Sarah M.
    Kanne, David B.
    Sivick, Kelsey E.
    Baird, Jason R.
    Lemmens, Edward
    Leong, Justin J.
    Metchette, Ken
    Crittenden, Mark
    Gough, Michael
    Gajewski, Thomas F.
    Dubensky, Thomas W., Jr.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [8] STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid leukemia
    Aikins, Marisa E.
    Sun, Xiaoqi
    Dobson, Hannah
    Zhou, Xingwu
    Xu, Yao
    Lei, Yu Leo
    Moon, James J.
    JOURNAL OF CONTROLLED RELEASE, 2024, 368 (768-779) : 768 - 779
  • [9] Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation
    Temizoz, Burcu
    Hioki, Kou
    Kobari, Shingo
    Jounai, Nao
    Kusakabe, Takato
    Lee, Michelle S. J.
    Coban, Cevayir
    Kuroda, Etsushi
    Ishii, Ken J.
    INTERNATIONAL IMMUNOLOGY, 2022, 34 (07) : 353 - 364
  • [10] Potent induction of a tumor-specific immune response by a cyclic dinucleotide STING agonist
    Gremel, Gabriela
    Impagnatiello, Maria A.
    Carotta, Sebastian
    Schaaf, Otmar
    Chetta, Paolo M.
    Oost, Thorsten
    Zichner, Thomas
    Hofmann, Marco
    Blake, Sophia
    Bretschneider, Tom
    Fleck, Martin
    Grube, Achim
    Nar, Herbert
    Rast, Georg
    Schmidt, Esther
    Klinkhardt, Ute
    Arndt-Schmitz, Kirsten
    Laux, Thorsten
    Zinzalla, Vittoria
    Sedgwick, Jonathon
    Kraut, Norbert
    CANCER RESEARCH, 2020, 80 (16)
12345